Gadolinium enhanced MR coronary vessel wall imaging at 3.0 Tesla

Sebastian Kelle, Kelly Schlendorf, Glenn A. Hirsch, Gary Gerstenblith, Eckart Fleck, Robert G. Weiss, Matthias Stuber

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose. We evaluated the influence of the time between low-dose gadolinium (Gd) contrast administration and coronary vessel wall enhancement (LGE) detected by 3T magnetic resonance imaging (MRI) in healthy subjects and patients with coronary artery disease (CAD). Materials and Methods. Four healthy subjects (4 men, mean age 29 3 years and eleven CAD patients (6 women, mean age 61 10 years) were studied on a commercial 3.0 Tesla (T) whole-body MR imaging system (Achieva 3.0 T; Philips, Best, The Netherlands). T1-weighted inversion-recovery coronary magnetic resonance imaging (MRI) was repeated up to 75 minutes after administration of low-dose Gadolinium (Gd) (0.1mmol/kg Gd-DTPA). Results. LGE was seen in none of the healthy subjects, however in all of the CAD patients. In CAD patients, fifty-six of 62 (90.3%) segments showed LGE of the coronary artery vessel wall at time-interval 1 after contrast. At time-interval 2, 34 of 42 (81.0%) and at time-interval 3, 29 of 39 evaluable segments (74.4%) were enhanced. Conclusion. In this work, we demonstrate LGE of the coronary artery vessel wall using 3.0 T MRI after a single, low-dose Gd contrast injection in CAD patients but not in healthy subjects. In the majority of the evaluated coronary segments in CAD patients, LGE of the coronary vessel wall was already detectable 3045 minutes after administration of the contrast agent.

Original languageEnglish (US)
Article number856418
JournalCardiology Research and Practice
Volume1
Issue number1
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Gadolinium enhanced MR coronary vessel wall imaging at 3.0 Tesla'. Together they form a unique fingerprint.

Cite this